Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol

Journal of Microencapsulation

Volumn 22, Issue 7, 2005, Pages 773-785

  Budhian, Avinash ^a   Siegel, Steven J ^b   Winey, Karen I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Controlled release; Drug delivery; Haloperidol; Nanoparticles; PLGA end groups

Indexed keywords

HALOPERIDOL; HYDROXYL GROUP; METHYL GROUP; NANOPARTICLE; POLYGLACTIN; POLYMER; SOLVENT;

ACCURACY; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG STRUCTURE; EMULSION; EVAPORATION; IN VITRO STUDY; MATERIALS; PARTICLE SIZE; PHYSICAL PARAMETERS; SOLID PHASE EXTRACTION; SUSPENSION;

DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; HALOPERIDOL; LACTIC ACID; NANOTECHNOLOGY; NANOTUBES; POLYGLYCOLIC ACID; POLYMERS;

EID: 31544464116     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040500273753     Document Type: Article

References (17)

1. Aberturas, MR and Molpeceres, J and Guzman, M and Garcia, F. (2002) Development of a new cyclosporine formulation based on poly(caprolactone) microspheres Journal of Microencapsulation, 19, pp. 61 - 72.
2. Allemann, E and Gurny, R and Leroux, JC.(1996) Boidegradable nanoparticles of poly(lactic-co-glycolic acid) for parenteral administration. In Pharmaceutical dosage forms: Disperse systems. (pp. 163 - 194). New York: Marcel Dekker.
3. Baichello, JM and Morishita, M and Takayama, K and Nagai, T. (1999) Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Development and Industrial Pharmacy, 25, pp. 471 - 476.
4. Birnbaum, DT and Kosmala, JD and Brannon-Peppas, L. (2000) Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles Journal of Nanoparticle Research, 2, pp. 173 - 181.
5. Bodmeier, R and McGinity, JW. (1987a) Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology Journal of Microencapsulation, 4, pp. 279 - 288.
6. Cappel, MJJK. (1991) Effect of nanoparticles on transdermal drug delivery Journal of Microencapsulation, 8, pp. 369 - 374.
7. Chorny, M and Fishbein, I and Danenberg, HD and Golomb, G. (2002a) Lipophilic drug loaded nanospheres prepared by nanoprecipitation: Effect of formulation variables on size, drug recovery and release kinetics Journal of Controlled Release, 83, pp. 389 - 400.
8. Chorny, M and Fishbein, I and Danenberg, HD and Golomb, G. (2002b) Study of the drug release mechanism from tyrphostin AG-1295 loaded nanospheres by in situ and external sink methods Journal of Controlled Release, 83, pp. 401 - 414.
9. Fessi, H and Puisieux, F and Devissaguet, JP and Ammoury, N and Benita, S. (1989) Nanocapsules formulation by interfacial polymer deposition following solvent displacement International Journal of Pharmaceutics, 55, pp. R1 - R4.
10. Gaspar, MMBD and Cruz, MEM and Alonso, MJ. (1998) Formulation of L-asparaginase-loaded poly(lactic-co-glycolide) nanoparticles: Influence of polymer properties on enzyme loading, acitvity and in vitro release Journal of Controlled Release, 52, pp. 53 - 62.
11. Jain, R and Shah, NH and Malick, AW and Rhodes, CT. (1998) Controlled drug delivery by biodegradable poly(ester) devices: Different preparative approaches Drug Development and Industrial Pharmacy, 24, pp. 703 - 727.
12. Lam, XMDET and Daugherty, AL and Levin, N and Cleland, JL. (2000) Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes Journal of Controlled Release, 67, pp. 281 - 292.
13. Nagata, STK and Hirano, K and Takagishi, Y. (1994) Pharmaceutical dosage form design of copoly (lactic/glycolic acid) microspheres Mechanism of in vitro release of gentamicin. Yakugaku Zasshi, 114, pp. 1005 - 1014.
14. Quintanar-Guerrero, D and Allemann, E and Doelker, E and Fessi, H. (1998) Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique Pharmaceutical Research, 15, pp. 1056 - 1062.
15. Siegel, SJKIW and Gur, RE and Lenox, RH and Bilker, WB and Ikeda, D and Gandhi, N and Zhang, W-X. (2002) Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia Neuropsychopharmacology, 26, pp. 817 - 823.
16. Soppimath, KS and Aminabhavi, TM. (2002) Ethyl acetate as a dispersing solvent in the production of poly(dl-lactide-co-glycolide) microspheres: Effect of process parameters and polymer type Journal of Microencapsulation, 19, pp. 281 - 292.
17. Takada, SOY. (1998) Design and development of controlled release of drugs from injectable microcapsules Nippon Rinsho, 56, pp. 675 - 679.